Cargando…

The effects of berberine on inflammatory markers in Chinese patients with metabolic syndrome and related disorders: a meta‑analysis of randomized controlled trials

BACKGROUND: A meta-analysis of randomized controlled trials (RCTs) was conducted to systematically evaluate the effects of berberine on the inflammatory markers of metabolic syndrome (MetS) and related disorders. METHOD: Databases that were searched from inception to October 2020 included PubMed, We...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lu, Yuqiong, Zhang, Xiwen, He, Jiafang, Dai, Zhanjing, Shi, Penghua, Lu, Yun, Chang, Feng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer International Publishing 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9135894/ https://www.ncbi.nlm.nih.gov/pubmed/35352233 http://dx.doi.org/10.1007/s10787-022-00976-2

Ejemplares similares

Whether and How Disutilities of Adverse Events were Used in the Economic Evaluation of Drug Therapy for Cancer Treatment
por: Lu, Yuqiong, et al.
Publicado: (2023)

Obtaining EQ-5D-3L utility index from the health status scale of traditional Chinese medicine (TCM-HSS) based on a mapping study
por: Wang, Li, et al.
Publicado: (2022)

Effects of bDMARDs on quality of life in patients with psoriatic arthritis: meta-analysis
por: Lu, Yuqiong, et al.
Publicado: (2022)

Efficacy and Safety of Berberine Alone for Several Metabolic Disorders: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
por: Ye, Yu, et al.
Publicado: (2021)

Metabolic disorder and intestinal microflora dysbiosis in chronic inflammatory demyelinating polyradiculoneuropathy
por: Fu, Jiafang, et al.
Publicado: (2023)

The mechanism of berberine alleviating metabolic disorder based on gut microbiome
por: Wang, Han, et al.
Publicado: (2022)

Acetylation of p65(Lys310) by p300 in macrophages mediates anti-inflammatory property of berberine
por: Zhang, Shuchen, et al.
Publicado: (2023)

Effects of berberine on glucose-lipid metabolism, inflammatory factors and insulin resistance in patients with metabolic syndrome
por: Cao, Changfu, et al.
Publicado: (2019)

Liver-target nanotechnology facilitates berberine to ameliorate cardio-metabolic diseases
por: Guo, Hui-Hui, et al.
Publicado: (2019)

Snoring, Inflammatory Markers, Adipokines and Metabolic Syndrome in Apparently Healthy Chinese
por: Sun, Liang, et al.
Publicado: (2011)

Pharmacological effects of berberine on mood disorders
por: Fan, Jie, et al.
Publicado: (2018)

Efficacy and safety of berberine for premature ventricular contractions: a meta-analysis and systematic review of randomized controlled trials
por: Qiao, Meng, et al.
Publicado: (2023)

Berberine improves glucogenesis and lipid metabolism in nonalcoholic fatty liver disease
por: Zhao, Li, et al.
Publicado: (2017)

Metabolic effect of berberine–silymarin association: A meta‐analysis of randomized, double‐blind, placebo‐controlled clinical trials
por: Fogacci, Federica, et al.
Publicado: (2019)

State-of-the-Art: Inflammatory and Metabolic Markers in Mood Disorders
por: Mucci, Federico, et al.
Publicado: (2020)

The Effect of Berberine on Reproduction and Metabolism in Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis of Randomized Control Trials
por: Xie, Liangzhen, et al.
Publicado: (2019)

The Effect of Berberine on Metabolic Profiles in Type 2 Diabetic Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Guo, Jing, et al.
Publicado: (2021)

Methyltransferase SETD2 mediates hepatoprotection of berberine against steatosis
por: Dai, Li, et al.
Publicado: (2022)

Berberine and Berberine-Containing Plants in Pharmacology and Therapeutics
por: Chopra, R. N., et al.
Publicado: (1932)

Associations of Amylin with Inflammatory Markers and Metabolic Syndrome in Apparently Healthy Chinese
por: Hou, Xinwei, et al.
Publicado: (2011)

Berberine in the Treatment of Type 2 Diabetes Mellitus: A Systemic Review and Meta-Analysis
por: Dong, Hui, et al.
Publicado: (2012)

Berberine alleviates lipid metabolism disorders via inhibition of mitochondrial complex I in gut and liver
por: Yu, Muyu, et al.
Publicado: (2021)

A New Therapeutic Candidate for Cardiovascular Diseases: Berberine
por: Cai, Yun, et al.
Publicado: (2021)

Berberine impairs coxsackievirus B3‐induced myocarditis through the inhibition of virus replication and host pro‐inflammatory response
por: Dai, Qian, et al.
Publicado: (2020)

Metabolic characterization and pathway analysis of berberine protects against prostate cancer
por: Li, Xianna, et al.
Publicado: (2017)

Berberine in Cardiovascular and Metabolic Diseases: From Mechanisms to Therapeutics
por: Feng, Xiaojun, et al.
Publicado: (2019)

Antioxidant and Anti-Inflammatory Activities of Berberine in the Treatment of Diabetes Mellitus
por: Li, Zheng, et al.
Publicado: (2014)

Berberine exerts an anti-inflammatory role in ocular Behcet's disease
por: Yang, Yan, et al.
Publicado: (2017)

Effects of Dietary Intervention on Inflammatory Markers in Metabolic Syndrome: A Systematic Review and Meta-Analysis
por: Wang, Mengjun, et al.
Publicado: (2022)

Berberine regulates glucose metabolism in largemouth bass by modulating intestinal microbiota
por: Xia, Yun, et al.
Publicado: (2023)

Anti-inflammatory activity of berberine in non-alcoholic fatty liver disease via the Angptl2 pathway
por: Lu, Zengsheng, et al.
Publicado: (2020)

Prognostic value of systemic inflammatory markers in ovarian Cancer: a PRISMA-compliant meta-analysis and systematic review
por: Zhu, Ying, et al.
Publicado: (2018)

Comparative study of antioxidant and antimicrobial activity of berberine-derived Schiff bases, nitro-berberine and amino-berberine
por: Alipour Noghabi, Soheila, et al.
Publicado: (2023)

Berberine: Botanical Occurrence, Traditional Uses, Extraction Methods, and Relevance in Cardiovascular, Metabolic, Hepatic, and Renal Disorders
por: Neag, Maria A., et al.
Publicado: (2018)

Effect of Psychobiotics on Psychometric Tests and Inflammatory Markers in Major Depressive Disorder: Meta-Analysis of Randomized Controlled Trials with Meta-Regression
por: Misera, Agata, et al.
Publicado: (2021)

Adipose Tissue SIRT1 Regulates Insulin Sensitizing and Anti-Inflammatory Effects of Berberine
por: Shan, Yun, et al.
Publicado: (2020)

Berberine Moderates Glucose and Lipid Metabolism through Multipathway Mechanism
por: Zhang, Qian, et al.
Publicado: (2011)

Berberine Inhibits MDA-MB-231 Cells by Attenuating Their Inflammatory Responses
por: Zhao, Lina, et al.
Publicado: (2020)

Atheroprotective Effects and Molecular Mechanism of Berberine
por: Xing, Lu, et al.
Publicado: (2021)

Pharmacokinetic interactions and tolerability of berberine chloride with simvastatin and fenofibrate: an open-label, randomized, parallel study in healthy Chinese subjects
por: Li, Guofei, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_9v8ag76cbb6ikok2a3jf7pv758